Free Access
Med Sci (Paris)
Volume 22, Number 8-9, Août–Septembre 2006
Page(s) 751 - 754
Section M/S revues
Published online 15 August 2006
  1. Kovacs JA, Baseler M, Dewar RJ,et al. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection : a preliminary study. N Engl J Med 1995; 332 : 567–75. [Google Scholar]
  2. Kovacs JA, Vogel S, Albert JM, et al. Sustained increases in CD4 counts with intermittent interleukin-2 therapy in HIV-infected patients with greater than 200 CD4 cells/mm3 : results of a randomized, controlled trial. N Engl J Med 1996; 335 : 1350–6. [Google Scholar]
  3. Davey RT, Chaitt DG, Piscitelli SC, et al. Subcutaneous administration of interleukin-2 in HIV-1 infected persons. J Infect Dis 1997; 175 : 781–9. [Google Scholar]
  4. Levy Y, Capitant C, Houhou S, et al. For the ANRS 048 study group. Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection : a randomised controlled trial. Lancet 1999; 353 : 1923–9. [Google Scholar]
  5. Davey RT, Chaitt DJ, Albert JM, et al. A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection. J Infect Dis 1999; 179 : 849–58. [Google Scholar]
  6. Davey RT, Murphy RL, Graziano FM, et al. Immunologic and virologic effects of subcutaneous interleukin-2 in combination with antiretroviral therapy : a randomized controlled trial. JAMA 2000; 284 : 183–9. [Google Scholar]
  7. Levy Y, Durier C, Krzysiek R, et al. Effects of interleukin-2 therapy combined with highly active antiretroviral treatment on immune restoration in HIV-1 infection : a randomized controlled trial. AIDS 2003; 17 : 343–51. [Google Scholar]
  8. Arduino RC, Nannini EC, Rodriguez-Barradas M, et al. CD4 cell response to 3 doses of subcutaneous interleukin 2 : meta-analysis of 3 vanguard studies. Clin Infect Dis 2004; 39 : 115–22. [Google Scholar]
  9. Gougeon ML, Rouzioux C, Liberman I, et al. Immunological and virological effects of long term IL-2 therapy in HIV-1-infected patient. AIDS 2001; 15 : 1729–31. [Google Scholar]
  10. Farel CE, Chaitt DG, Hahn BK, et al. Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection. Blood 2004; 103 : 3282–6. [Google Scholar]
  11. Sereti I, Martinez-Wilson H, Metcalf JA, et al. Long-term effect of intermittent interleukin-2 therapy in patients with HIV infection : characterization of a novel subset of CD4+/CD25+ T cells. Blood 2002; 100 : 2159–67. [Google Scholar]
  12. Sereti I, Anthony KB, Martinez-Wilson H, et al. IL-2-induced CD4+ T cell expansion in HIV-infected patients is associated with long term decreases in T-cell proliferation. Blood 2004; 104 : 775–80. [Google Scholar]
  13. Kovacs JA, Lempicki RA, Sidorov IA, et al. Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients. J Clin Invest 2005; 115 : 2139–48. [Google Scholar]
  14. Sereti I, Imamichi H, Natarajan V, et al. In vivo expansion of CD4+CD45RO-CD25+ T cells expressing foxP3 in IL-2 treated HIV-infected patients. J Clin Invest 2005; 115 : 1839–47. [Google Scholar]
  15. Weiss L, Donkova-Petrini V, Aouba A, Levy Y. CD4+CD25+ regulatory T cells are detectable in peripheral blood of HIV-infected patients treated with IL-2. Rio de Janeiro : 3rd IAS Conference, 2005 : We.Pe.16.5.B06 (abstract). [Google Scholar]
  16. Weiss, L, Donkova-Petrini, V, Caccavelli, L, et al. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004; 101 : 3249–56. [Google Scholar]
  17. Kinter A, Hennessey M, Bell A, et al. CD25+CD4+ regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4+ and CD8+ HIV-specific T cell immune responses in vitro and are associated with favourable clinical markers of disease status. J Exp Med 2004; 200 : 331–43. [Google Scholar]
  18. Blattman JN, Grayson JM, Wherry EJ, et al. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat Med 2003; 9 : 540–7. [Google Scholar]
  19. Valdez H, Mitsuyasu R, Landay A, et al. Interleukin-2 induces increases in CD4+ lymphocyte numbers but does not enhance responses to immunization : results of A5046s. J Infect Dis 2003; 187 : 320–5. [Google Scholar]
  20. Levy Y, Gahery-Segard H, Durier C, et al. Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patient. AIDS 2005; 19 : 279–86. [Google Scholar]
  21. Barouch DH, Santra S, Steenbeke TD, et al. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. J Immunol 1998; 161 : 1875–82. [Google Scholar]
  22. ESPRIT IL-2 trial (online) [Google Scholar]
  23. SILCAAT study design (online) [Google Scholar]
  24. Fry TJ, Mackall C. Interleukin-7 : from bench to clinic. Blood 2002; 99 : 3892–904. [Google Scholar]
  25. Bolotin E, Annett G, Parkman R, Weinberg K. Serum levels of IL-7 in bone marrow transplant recipients : relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplant 1999; 8 : 783–8. [Google Scholar]
  26. Napolitano LA, Grant RM, Deeks SG, et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion. Implications for T cell homeostasis. Nat Med 2001; 7 : 73–9. [Google Scholar]
  27. Smithgall MD, Wong JG, Critchett KE, Haffar OK. IL-7 up-regulates HIV-1 replication in naturally infected peripheral blood mononuclear cells. J Immunol 1996; 156 : 2324–30. [Google Scholar]
  28. Steffens CM, Managlia EZ, Landay A, Al-Harthi L. Interleukin-7 treated naïve T cells can be productively infected by T-cell-adapted and primary isolates of human immunodeficiency virus 1. Blood 2002; 99 : 3310–8. [Google Scholar]
  29. Fry TJ, Moniuszko M, Creekmore S, et al. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood 2003; 101 : 2294–9. [Google Scholar]
  30. Nugeyre MT, Monceaux V, Beq S, et al. IL-7 stimulates T cell renewal without increasing viral replication in simian immunodeficiency virus-infected macaques. J Immunol 2003; 171 : 4447–53. [Google Scholar]
  31. Wang FX, Xu Y, Sullivan J, et al. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. J Clin Invest 2005; 115 : 128–37. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.